Company
3E Bioventures Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Acclaro Medical | Series B | 2025-05-29 | |
| Rapafusyn Pharmaceuticals | Series A Funding | 2024-06-24 | Lead |
| Larkspur Biosciences | Financing | 2023-05-24 | Lead |
Company
| Company | Round | Date | Lead |
|---|---|---|---|
| Acclaro Medical | Series B | 2025-05-29 | |
| Rapafusyn Pharmaceuticals | Series A Funding | 2024-06-24 | Lead |
| Larkspur Biosciences | Financing | 2023-05-24 | Lead |